about
Basic pharmacokinetics of bisoprolol, a new highly beta 1-selective adrenoceptor antagonistRapid chiral separation of metoprolol in plasma--application to the pharmacokinetics/pharmacodynamics of metoprolol enantiomers in the conscious goat.Drug interaction between propafenone and metoprolol.Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studiesThe effect of pretreatment with cimetidine on the bioavailability and disposition of atenolol and metoprolol.Lack of a pharmacokinetic interaction between nifedipine and the beta-adrenoceptor blockers metoprolol and atenololInfluence of food on the absorption of metoprolol administered as an Oros drug delivery system to manInvestigation of drug absorption from the gastrointestinal tract of man. III. Metoprolol in the colon.Drug disposition and modelling before and after gastric bypass: immediate and controlled-release metoprolol formulationsOphthalmic drug design based on the metabolic activity of the eye: soft drugs and chemical delivery systems.Clinically important interaction between metoprolol and propafenone.Pharmacogenetic profiling in the treatment of heart disease.Adrenergic signaling polymorphisms and their impact on cardiovascular disease.Defective metabolism of metoprolol in poor hydroxylators of debrisoquine.Gastric, intestinal and colonic absorption of metoprolol in the rat.An evaluation of the perioperative efficacy of selective beta 1-blockade in coronary surgery. Studies with a late preoperative dose of metoprolol.Lack of evidence for polymorphism in metoprolol metabolism.Investigation of drug absorption from the gastrointestinal tract of man. IV. Influence of food and digestive secretions on metoprolol jejunal absorption.Osmotically controlled-delivery of metoprolol in man: in vivo performance of Oros systems with different durations of drug release.Polymorphic metabolism of beta-adrenoceptor antagonists.The effect of cimetidine on the relative cardioselectivity of atenolol and metoprolol in asthmatic patients.Comparison of two long-acting preparations of metoprolol with conventional metoprolol and atenolol in healthy men during chronic dosing.An investigation of CYP2D6 genotype and response to metoprolol CR/XL during dose titration in patients with heart failure: a MERIT-HF substudy.Effects of polymorphism of the beta(1) adrenoreceptor and CYP2D6 on the therapeutic effects of metoprolol.Differential effects of carvedilol and metoprolol succinate on plasma norepinephrine release and peak exercise heart rate in subjects with chronic heart failure.Failed heart rate control with oral metoprolol prior to coronary CT angiography: effect of additional intravenous metoprolol on heart rate, image quality and radiation dose.β-Blocker Dialyzability in Maintenance Hemodialysis Patients: A Randomized Clinical Trial.
P2860
Q28282702-F8FBA050-80B4-4AE6-ADA5-276079120829Q30805051-AD684FA8-C509-4FA8-B9AA-2D2F7FF90F71Q34420988-96295B1C-9C07-4C1E-B44E-722C355BAF42Q34447046-891C5599-3355-4B93-A45F-E389FFE9755DQ34511658-9169FFE8-3249-40B1-B0BE-16A2F68F3386Q34621951-97490E57-FE11-4D11-81DF-AD13384B03BBQ34622407-CF97EC7E-E3A5-4362-B28E-4D60AF05D1ADQ34622413-347D7285-27A3-4347-A591-D2C807A75ED9Q36243622-F536483C-F488-4310-B993-EE66BD9CDB7BQ36440361-BF545AB5-EFFA-41C1-B9D7-78B20D5FC9FEQ36762067-B0942FE0-CDF5-40D9-96C3-365E09DB6C96Q37636713-807613C8-1D23-47CE-8BDE-F7DAC9FD6261Q37776088-DBAD8EA4-9CA3-4308-8163-071CAB1C032EQ41760769-DE8EB7C9-E3D5-4085-BAEA-248A909141AAQ41840893-4BDBA1BC-8EE2-4329-BE21-5BC78E5F6C32Q41914230-2146BBBF-596C-44FE-B7AD-ED09B6F44FAAQ41997634-2E16280B-0A94-4316-AAAF-A29D81187FC0Q42054135-03C80C62-4C10-440F-9EBE-A319877FBAB8Q42531013-149B8A58-00B2-4BD9-9E36-A843CE0C6842Q42532367-BDE28C7A-4EA1-443A-B2DF-3C4AA1617312Q42532396-18FB2D78-1C4A-4914-8FD2-436C71002BAFQ42639468-D3F650D9-372B-460F-8766-282F9B604CADQ43423712-B3F02633-3192-43FC-9EBD-931A78AC3825Q46191457-EF536E16-72E5-475E-9E27-836ED77D0243Q46743813-51C81319-7CA7-4A81-9163-ED88FDF7FFDFQ53164938-B50E066C-799C-4596-8408-333123CFFF7EQ53838798-3200C5B6-8BD8-4388-9433-AA33EB4884D6
P2860
description
1980 nî lūn-bûn
@nan
1980 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1980 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1980年の論文
@ja
1980年論文
@yue
1980年論文
@zh-hant
1980年論文
@zh-hk
1980年論文
@zh-mo
1980年論文
@zh-tw
1980年论文
@wuu
name
Clinical pharmacokinetics of metoprolol.
@ast
Clinical pharmacokinetics of metoprolol.
@en
Clinical pharmacokinetics of metoprolol.
@nl
type
label
Clinical pharmacokinetics of metoprolol.
@ast
Clinical pharmacokinetics of metoprolol.
@en
Clinical pharmacokinetics of metoprolol.
@nl
prefLabel
Clinical pharmacokinetics of metoprolol.
@ast
Clinical pharmacokinetics of metoprolol.
@en
Clinical pharmacokinetics of metoprolol.
@nl
P1476
Clinical pharmacokinetics of metoprolol.
@en
P2093
Johnsson G
Regårdh CG
P304
P356
10.2165/00003088-198005060-00004
P577
1980-11-01T00:00:00Z
P6179
1019129075